Using immunofluorescence, Huang et al. demonstrated that there is a reduction in the AQP4 expression in the PVS in mice with NTG induced migraine, especially in those simultaneously treated with an AQP4 inhibitor (TGN-020). Here, AQP4 is linked to migraine disorder.